These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2334412)

  • 1. Enhanced binding activity of an apolipoprotein E mutant, APO E5, to LDL receptors on human fibroblasts.
    Dong LM; Yamamura T; Yamamoto A
    Biochem Biophys Res Commun; 1990 Apr; 168(2):409-14. PubMed ID: 2334412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed mutagenesis of an apolipoprotein E mutant, apo E5(Glu3----Lys) and its binding to low density lipoprotein receptors.
    Dong LM; Yamamura T; Tajima S; Yamamoto A
    Biochem Biophys Res Commun; 1992 Sep; 187(2):1180-6. PubMed ID: 1530612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of apolipoprotein E7 (Glu(244)-->Lys, Glu(245)--->Lys), a mutant apolipoprotein E associated with hyperlipidemia and atherosclerosis.
    Yamamura T; Dong LM; Yamamoto A
    J Lipid Res; 1999 Feb; 40(2):253-9. PubMed ID: 9925654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
    Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
    Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
    Innerarity TL; Friedlander EJ; Rall SC; Weisgraber KH; Mahley RW
    J Biol Chem; 1983 Oct; 258(20):12341-7. PubMed ID: 6313652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of apo E secretion on lipoprotein uptake in transfected cells.
    Shimano H; Fukazawa C; Shibasaki Y; Mori N; Gotoda T; Harada K; Shimada M; Yamada N; Yazaki Y; Takaku F
    Biochim Biophys Acta; 1991 Nov; 1086(3):245-54. PubMed ID: 1742315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E polymorphism and coronary heart disease.
    Yamamura T; Dong LM; Yamamoto A
    Chin Med J (Engl); 1992 Sep; 105(9):738-41. PubMed ID: 1288976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new isoform of apolipoprotein E--apo E-5--associated with hyperlipidemia and atherosclerosis.
    Yamamura T; Yamamoto A; Hiramori K; Nambu S
    Atherosclerosis; 1984 Feb; 50(2):159-72. PubMed ID: 6712769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts.
    Datta G; Chaddha M; Garber DW; Chung BH; Tytler EM; Dashti N; Bradley WA; Gianturco SH; Anantharamaiah GM
    Biochemistry; 2000 Jan; 39(1):213-20. PubMed ID: 10625496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2.
    Tam SP; Zhang X; Koschinsky ML
    J Lipid Res; 1996 Mar; 37(3):518-33. PubMed ID: 8728315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
    Al-Haideri M; Goldberg IJ; Galeano NF; Gleeson A; Vogel T; Gorecki M; Sturley SL; Deckelbaum RJ
    Biochemistry; 1997 Oct; 36(42):12766-72. PubMed ID: 9335533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of high density lipoprotein binding to human adipocyte plasma membranes.
    Fong BS; Rodrigues PO; Salter AM; Yip BP; Despres JP; Angel A; Gregg RE
    J Clin Invest; 1985 Jun; 75(6):1804-12. PubMed ID: 2989332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor.
    Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N
    Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformationally specific enhancement of receptor-mediated LDL binding and internalization by peptide models of a conserved anionic N-terminal domain of human apolipoprotein E.
    Braddock DT; Mercurius KO; Subramanian RM; Dominguez SR; Davies PF; Meredith SC
    Biochemistry; 1996 Nov; 35(44):13975-84. PubMed ID: 8909295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
    Krul ES; Tikkanen MJ; Cole TG; Davie JM; Schonfeld G
    J Clin Invest; 1985 Feb; 75(2):361-9. PubMed ID: 3973009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Chappell DA
    J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
    Fan J; Ji ZS; Huang Y; de Silva H; Sanan D; Mahley RW; Innerarity TL; Taylor JM
    J Clin Invest; 1998 May; 101(10):2151-64. PubMed ID: 9593771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of exogenous apo E on the cellular binding of lipoproteins.
    Mokuno H; Ishibashi S; Shimano H; Gothoda T; Takaku F; Yamada N
    Gerontology; 1990; 36 Suppl 1():42-8. PubMed ID: 2384229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes.
    Cenarro A; Etxebarria A; de Castro-Orós I; Stef M; Bea AM; Palacios L; Mateo-Gallego R; Benito-Vicente A; Ostolaza H; Tejedor T; Martín C; Civeira F
    J Clin Endocrinol Metab; 2016 May; 101(5):2113-21. PubMed ID: 27014949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial apolipoprotein E-beta-galactosidase fusion protein expressed in Escherichia coli retains binding activity to the LDL(B/E) receptor.
    Ribeiro A; Cardot P; Benarous R; Pernas P; Pepin D; Rybkine T; Chambaz J; Bereziat G
    Biochim Biophys Acta; 1990 Oct; 1087(2):219-25. PubMed ID: 2223883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.